The Patent Finder

Agenebio, Inc.

Also on record
Records under this name other than the patents Agenebio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 4 of 4 · Back to Agenebio, Inc.

PatentTitleStatus Expires Confidence
US 11,312,721Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
Lapsed on the fee record
Ended Apr 26, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 26, 2026From the USPTO record
US 11,160,785Methods and compositions for improving cognitive function
Lapsed on the fee record
Ended Nov 2, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 2, 2025From the USPTO record
US 9,801,879Pyridazine derivatives, compositions and methods for treating cognitive impairment
Lapsed on the fee record
Ended Oct 31, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 31, 2025From the USPTO record
US 9,145,372Pyridazine derivatives, compositions and methods for treating cognitive impairment
Lapsed on the fee record
Ended Sep 29, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 29, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited